ChemioCare Expands Proprietary Transdermal Platform
18. Oktober 2018 20:11 ET
|
ChemioCare
DEA Registration granted: expands capability to develop controlled substances via transdermal patches NEW YORK, Oct. 18, 2018 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the...